LSE : 0HCK.L

Align Technology, Inc.

$168.6207 USD

$2.52 (1.52%)

Volume
141
Average Volume
944
Market Capitalization
$12.08B
P/E Ratio
27.98
Dividend Yield
0.00%
Price Target
Year High
$411.53
Year Low
$165.10
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.39
Company Overview

LSE

Joseph Hogan

Medical - Devices

Healthcare

0HCK.L

20945

US

USD

https://www.aligntech.com

408 470 1000

016255101

N/A

Liquidity Metrics

0.03

1.39

1.28

0.56

0.00

Sales & Valuation

$4.03B

2.92

2.87

17.43

9.61

Profitability

$5.65

$410.35M

10.50%

14.50%

10.70%

6.81%

P/E Metrics

27.98

3.20

3.20

Analyst Price Target & Rating

Neutral

3/5

29 Analysts

%

Financial Health Scores

5.01

8/9

$749.58M

$6.31B

$2.16B

$681.9M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
David Carr Executive VP and MD of EMEA
Srini Kaza Executive Vice President of Research & Development
Shirley Stacy Vice President of Corporation Communications & Investor Relations
Mitra Derakhshan Executive VP, Chief Clinical Officer, Global Treatment Planning & Clinical Services
Richardson Jaime Holte Executive Vice President of Global Human Resources
Sreelakshmi Kolli Executive Vice President & Chief Product and Digital Officer
Zelko Relic Executive Vice President & Chief Technology Officer
John F. Morici Chief Financial Officer & Executive Vice President of Global Finance
Joseph Hogan President, Chief Executive Officer & Director
Julie Ann Coletti Executive Vice President and Chief Legal & Regulatory Officer
Emory Wright Executive Vice President of Direct Fabrication Platform & Operations
Poll Results

No votes yet today — be the first to share your view!

About Align Technology, Inc. (LSE:0HCK.L) Stock

Align Technology, Inc., a prominent medical device company, is dedicated to developing, producing, and commercializing innovative solutions for dental professionals. Its core offerings include the well-known Invisalign clear aligner system and the iTero line of intraoral scanners, complemented by associated services. The company caters to orthodontists, general dentists, and practitioners specializing in restorative and aesthetic dentistry. Its operations are primarily organized into two divisions: The Clear Aligner segment encompasses a comprehensive range of Invisalign products. This includes full treatment solutions like Invisalign comprehensive, tailored for adolescent patients and incorporating advanced features such as mandibular advancement, compliance indicators, and compensation f ... or tooth eruption. It also offers specialized packages for younger children (typically ages seven to ten) with mixed dentition, known as Invisalign First Phase I and Invisalign First Comprehensive Phase 2. Beyond these extensive treatments, the segment provides less comprehensive options, including Invisalign moderate, lite, express packages, and Invisalign Go. Additionally, it supplies non-case related items such as retention devices, charges for Invisalign training, and sells supplementary products like cleaning materials and adjusting instruments utilized by dental professionals during treatment. The Scanners and Services segment focuses on the iTero scanner, a unified hardware platform equipped with various software functionalities for both restorative and orthodontic procedures. Its software for restorative dentistry serves general practitioners, prosthodontists, periodontists, and oral surgeons, while the orthodontic software aids practitioners in digital record keeping, diagnosis, and the creation of printed models and retainers. This segment further extends its offerings with computer-aided design and manufacturing (CAD/CAM) services, essential accessories like disposable wand sleeves, iTero models and dies, and supports third-party scanners and digital scans. Noteworthy innovations include the Invisalign Outcome Simulator, a chairside and cloud-based application for the iTero scanner, the Invisalign Progress Assessment Tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans with current data. Align Technology distributes its products across global markets, including significant presence in the United States, Switzerland, and China. Established in 1997, the company maintains its corporate headquarters in Tempe, Arizona.

Frequently Asked Questions

What is the current Align Technology, Inc. (0HCK.L) stock price?

Align Technology, Inc.(LSE:0HCK.L) stock price is $168.6207 in the last trading session. During the trading session, 0HCK.L stock reached the peak price of $411.5347 while $165.1 was the lowest point it dropped to. The percentage change in 0HCK.L stock occurred in the recent session was 1.52% while the dollar amount for the price change in 0HCK.L stock was $2.52.

0HCK.L's industry and sector of operation?

The LSE listed 0HCK.L is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of 0HCK.L?

David Carr | Executive VP and MD of EMEA
Srini Kaza | Executive Vice President of Research & Development
Shirley Stacy | Vice President of Corporation Communications & Investor Relations
Mitra Derakhshan | Executive VP, Chief Clinical Officer, Global Treatment Planning & Clinical Services
Richardson Jaime Holte | Executive Vice President of Global Human Resources

How many employees does 0HCK.L have?

Number of 0HCK.L employees currently stands at 20945. 0HCK.L operates from 410 North Scottsdale Road, Tempe, AZ 85281, US.

Link for 0HCK.L official website?

Official Website of 0HCK.L is: https://www.aligntech.com

How do I contact 0HCK.L?

0HCK.L could be contacted at phone #408 470 1000 and can also be accessed through its website. 0HCK.L operates from 410 North Scottsdale Road, Tempe, AZ 85281, US.

How many shares of 0HCK.L are traded daily?

The average number of 0HCK.L shares traded daily for last 3 months was 944.

What is the market cap of 0HCK.L currently?

The market value of 0HCK.L currently stands at $12.08B with its latest stock price at $168.6207